A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 56, Issue 1, 2001, Pages 50-57

  Devalia, J L ^a,c   Hanotte, F ^b   Baltes, E ^b   De Vos, C ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b UCB PHARMA   (Belgium)

^c NONE   (United Kingdom)

Author keywords

Antihistamines; Cetirizine; Equivalence; Levocetirizine; ucb 28557; Urinary excretion; Urticaria

Indexed keywords

CETIRIZINE; HISTAMINE H1 RECEPTOR ANTAGONIST; LEVOCETIRIZINE; UCB 28557; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EXCRETION; DRUG POTENCY; DRUG URINE LEVEL; ENANTIOMER; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN ALLERGY; URTICARIA;

ADOLESCENT; ADULT; ANTI-ALLERGIC AGENTS; CETIRIZINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; SKIN TESTS; STEREOISOMERISM;

EID: 0035145174     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2001.00726.x     Document Type: Article

References (25)

1. Assessment of urticaria and angio-oedema
2. Allergy and the skin. I. Urticaria
3. Urticaria - Pathophysiology
4. 2 release and the effect of oral corticosteroid administration
5. Determinants of in vivo histamine release in cutaneous allergic reactions in humans
6. Antihistamines in the treatment of asthma
7. 1-receptor antagonism
8. Mediators and nasal allergy
9. Histamine and asthma
10. 1-antagonists
11. 1-receptor antagonists)
12. Urticaria - Diagnosis and treatment
13. 1 antagonists in the management of the itch of urticarias
14. Cetirizine: A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders
15. Receptor effects of cetirizine
16. Antihistamines
17. A comparison of the two one-sided tests procedure and power approach for assessing the bioequivalence of average bioavailability
18. Update on the statistical analysis of bioequivalence studies
19. A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine, versus placebo: Suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects
20. A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: Suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects
21. Inhibitory effects of orally or sublingually administered cetirizine on histamine-induced wheals, flares and their correlation with cetirizine plasma concentrations
22. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis
23. Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma and chronic urticaria
24. Onset of action in the nasal antihistaminic effect of cetirizine and loratadine in patients with allergic rhinitis
25. Nasal effect of cetirizine and loratadine at 24 hours in patients with allergic rhinitis